Tatsuhiro Shibata and colleagues molecularly characterize 260 biliary tract cancer samples by a combination of exome and transcriptome sequencing. They find genomic alterations that could potentially be therapeutic targets.
- Hiromi Nakamura
- Yasuhito Arai
- Tatsuhiro Shibata